Language
English
Publication Date
10-1-2025
Journal
Journal of Surgical Oncology
DOI
10.1002/jso.70075
PMID
40958736
PMCID
PMC12501933
PubMedCentral® Posted Date
9-17-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Peritoneal malignancy often indicates disruptions in multiple physiological systems resulting from widespread cancer. The heterogenous origin and dynamic nature of peritoneal cancer make it difficult to treat with standard approaches that fit into guidelines. We describe how successful treatment should address the underlying pathology, the systemic response to surgical treatments and target the immune perturbations that facilitate the establishment and propagation of this multifaceted disease.
Keywords
Humans, Peritoneal Neoplasms, Immunotherapy, immunotherapy, peri‐operative immunity, peritoneal cancer, peritoneum, surgery
Published Open-Access
yes
Recommended Citation
Ozcan, Ada I; López, Arianexys Aquino; McKenna, Mary K; et al., "Peritoneal Immunosurgery: Immunotherapy Augmented Surgery for the Treatment of Peritoneal Cancers" (2025). Faculty and Staff Publications. 1537.
https://digitalcommons.library.tmc.edu/baylor_docs/1537
Included in
Biological Phenomena, Cell Phenomena, and Immunity Commons, Genetic Phenomena Commons, Genetic Processes Commons, Geriatrics Commons, Internal Medicine Commons